Total Utang marang Modal Callan JMB Corp (CJMB)

Callan JMB Inc (CJMB) develops high-precision trauma systems, focusing on limb salvage in complex clinical cases. The company is currently expanding rapidly by offering robotic intervention solutions that accelerate patient rehabilitation. This chart illustrates a total debt-to-equity ratio of 3.08. Business profitability is driven by the sale of spinal implants and instruments for the hospital sector.

CJMB: Rasio Utang marang Ekuitas Callan JMB Inc. 06.02.2025 - 29.10.2026

Rincian analitis perusahaan Callan JMB Inc

- rega lan prakiraan konsensus rega:
Bagan rega Callan JMB Inc.|CJMB - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar Callan JMB|CJMB - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Buku saben Saham Callan JMB|CJMB - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku callanjmb.com|CJMB - Gunggung Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Callan JMB Inc|CJMB - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Callan JMB Inc.|CJMB - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Callan JMB|CJMB - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Callan JMB
Analisis dhasar perusahaan:CJMB, Callan JMB Inc

Investors must assess the stability of Callan JMB Inc. (CJMB), as the large-scale implementation of AI control and robotic lines requires significant capital expenditures. When analyzing changes in the total debt-to-equity ratio, it is essential to consider that this metric measures the proportion of borrowed funds relative to equity, determining the degree of financial leverage and bankruptcy risks should the company's operating income contract.

Pesaing wigati

Utang marang Ekuitas Intuitive|Rasio Total Utang marang Ekuitas Danaher Corporation (DHR)|Total Utang marang Modal BDX|STE - Utang marang Modal|Total Utang marang Modal WST (West Pharmaceutical Services)|BAX: Rasio Utang marang Ekuitas|Masimo - Total Utang marang Modal|Koefisien Total Utang marang Modal Stevanato Group SpA STVN|TFX: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Merit Medical Corp|NVST (Envista Holdings) - Total Utang marang Modal|Total Utang marang Modal icumed.com|Utang marang Ekuitas Dentsply Sirona (XRAY)|Utang marang Ekuitas LMAT (LeMaitre Vascular Inc)|AtriCure Corp - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi STAA|ChromaDex Corp. - Total Utang marang Modal|Koefisien Total Utang marang Modal zimvie.com ZIMV|AngioDynamics (ANGO) - Utang marang Ekuitas|Rasio Utang marang Ekuitas CERS|Utang marang Ekuitas Alpha Teknova Inc|Monogram Orthopedics Inc. (MGRM) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas STSS (Sharps Technology, Inc.)|Utang Agregat marang Modal INFU|Utang marang Ekuitas Utah Medical Products, Inc. UTMD|Rasio Kabeh Utang marang Dana Pribadi KRMD|NYXH: Rasio Total Utang marang Ekuitas|MBOT - Total Utang marang Modal|Pro-Dex, Inc. (PDEX) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas zentek.com|ELUT (Elutia) - Total Utang marang Modal|Utang marang Modal Milestone Scientific Inc MLSS|Utang marang Ekuitas NEXGEL, Inc (NXGL)|retractable.com - Rasio Utang marang Ekuitas|Harvard Bioscience, Inc. - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal FEMY (femasys.com)|MHUA - Utang marang Ekuitas|Koefisien Total Utang marang Modal Predictive Oncology POAI|ATRI: Total Utang marang Modal|Rasio Total Utang marang Ekuitas NeuroMetrix Corporation